The Board of Directors of MBSB has recommended a Single-Tier Final Dividend of 3.0 sen net per Ordinary Share for the financial year ended 31 December 2019 ("Proposed Dividend").
Based on the total number of ordinary shares issued of 6,713,401,615 as at 31 December 2019, the Proposed Dividend payable would be approximately RM201.4 million.
The Board of Directors has determined that the option to reinvest via the Dividend Reinvestment Plan ("DRP") shall apply to the entire portion of the Proposed Dividend. The approval for the Proposed Dividend will be sought at the coming Annual General Meeting.
Under DRP, shareholders will have the following options in respect of the electable portion:-
(a) elect to exercise the option and thereby reinvest the entire electable portion (or a part thereof) at the issue price of the new MBSB shares ("DRP Price") and to receive cash for the remaining portion of the dividend (in the event that only part of the electable portion is reinvested); or
(b) elect not to exercise the option to reinvest and thereby receive their entire dividend entitlement wholly in cash.
There will be no brokerage fees and other related transaction costs payable by shareholders on the new MBSB shares allotted pursuant to the DRP.
The Books Closure date in respect of the Proposed Dividend will be announced after the Annual General Meeting.
If i am not wrong, there is no time limit for conversion of the preference shares to ordinary shares. The only disadvantages of the preference shares are minimal i.e no voting rights and highly unmarketable. If one intend to stay put on investing in the company because it is a good investment, then it is better not to convert at all. The dividend for the preference shares is much higher than the ordinary shares. Hence with the higher payout, why go for a lower one.
A good counter will stand all the volatility of the stock market. Allianz was pushed down to 11.30 in march. Within two and half months it goes back to above 15.00. This is a really good company with strong fundamentals and growth potential. If you have this stock, just keep it for long term investment and see the capital appreciation over time. Another Nestle in the making.
Basic EPS is 94.82 sen (diluted EPS 48.45 sen) versus 66.57 sen (33.99 sen) a year ago. On appearance a 42% increase is an extraordinary result.
However, the consolidated P&L shows that there is a fair value gain of RM368 million (versus FV gain RM128 million a year ago). This is probably contributed by the fixed income investment due to lower interest rate.
Part B Note 1.3 also mentions higher PBT for the general insurance segment is mainly due to lower motor claims ratio during MCO period. This is likely to be a one-time effect too. Claim ratio in Q2 is 54.5% versus 61.1% a year ago.
But it is still good result. Gross earned premium at RM1,228 million is higher than a year ago, although slightly lower than RM1,306 million in Q1.
Twin engines support growth Allianz’s 1H20 results were above our expectations, due largely to strong investment gains, though topline growth was marginally better than expected as well. Forecasts are maintained for now pending its analyst briefing but as it stands, Allianz is one of the best managed insurance companies in the industry and the twin exposure to both life and general insurance is very much complementary. BUY maintained with an unchanged SOTP-derived TP of MYR16.75.
Above expectations
Allianz reported a 2Q20 net profit of MYR168m (+43% YoY, +111% QoQ) leading to a 1H20 net profit of MYR247m (+14% YoY). The results were significantly above our expectations at 58% of our full-year forecast, supported mainly by strong MTM investment gains, given the decline in bond yields during the quarter. Topline nevertheless did surprise positively as well, with growth in the gross written premiums of both the life and general insurance businesses, despite the Mandatory Control Order (MCO).
@ kywoo, I read you comment on 23/03/2020. You mentioned "Thirdly, on conversion to ordinary shares you will get conversion rate of less than 1 to 1 basis."
I've tried to figure out the ICPS conversion ratio. The Annual Report of 2019 seems to imply conversion ratio is 1 to 1. It said "During the financial year, the Company increased its ordinary shares to 176,887,639 by the issuance of 199,200 ordinary shares pursuant to the conversion of 199,200 ICPS"
However, according to the circular below, Clause 4.10 (B) in page 9 states "that number of new AMB share(s) that holder of each ICPS is entitled to receive .... shall be multipled with the following formula:- revised number of AMB share/ original number of AMB share".
Do you refer to this formula? I have no idea what it is talking about. If you do can you explain? Is there any cost involved in conversion?
Clause 4.10 (A) also mentions the tenure is perpetual. So I think you're right that there is no time limit for conversion (unless it's forced conversion during winding up/liquidation).
That brings me to another question. 23 millions ICPS have been converted since 2011. Why did ICPS holders want to convert to ordinary shares?
Did it have to do with price? I note in certain years ICPS price tended to transact at a discount but at other years at a premium.
Or ease of selling? But that only make sense for large quantity selling. For a small quanitty, selling the ICPS directly in the illiquid market may still be faster than waiting for conversion into ordinary shares.
Could be due to price or sometimes the ICPS is less tradable. It should be 1 to 1 ratio. The reason that it was created could he because of shareholding conditions imposed on foreign held companies
Conversion ratio is 1 to 1, ie. one(1) ICPS to one (1) ordinary. One of the reason for conversion is due to liquidity and low volume of ICPS as holding company of AMB is holding 85% and the rest are mainly hold by funds. Converting to ordinary shares - easier to sell.
The utmost benefit of holding ICPS - it entitles to 1.2x more dividend (or 20% more) than ordinary shareholders.
ICPS is very not liquid and low volume due to reasons abovementioned. So the price over the period may not be representative whereby it may not move along with ordinary shares immediately. Generally, it should be at premium due to 1.2x dividend entitlement given Allianz Malaysia is declaring increasing and good dividend in recent years with adopted dividend payout policy.
kywoo, you are sharp and spotted the market trend, as evidenced in its Q2 QR. 64% topline of Allianz General is in motor business and stands to benefit from lower motor claims during MCO and even RMCO as many companies practice working from home nowadays, reduced traffics on the roads and less accidents (claims).
---------------------- kywoo If you follow Berkshire Hathaway general insurence quarterly result, you will note they make higher profit from motor insurance business because of less travel,thus less accidents, thus less motor claims and thus better profit margin. As Allianz is market leader in motor insurance business in Malaysia, it will benefit from better profit from their insurence becausr of lesser claims. March,April and May will be good months Like it or not, you have to insure for vehicles even if you travel less 03/05/2020 2:33 PM
I agree the ICPS should be at a premium given dividend is 1.2X. However the low liqudity works against it, especially if there are more ICPS sellers than buyers, who are mostly long term investors.
May be that explains the continous conversion over the years. But the ocnversion pace has slowed since 2019.
Solid Q2 performance. Thanks for sharing the analyst briefing slides.
Slide 25 shows that investment income this year dropped by almost RM476m (as compared to 2019). The breakdown indicates that most of the investment loss is passed to their par and investment linked policyholders and not the shareholders, this explains why the life insurance business is doing fine despite much lower investment return as they are not taking excessive investment risks in their non-participating and shareholders' fund. Interesting to note that they also don't have the negative impact of lower interest rate. The asset/liability management must be very done. The main concern is life new premium dropped 46% in the second quarter from 167.8m to 90.8m due to MCO.
Their general insurance business is very stable, hope they continue to enjoy lower claim in 3Q as many still working from home.
The unique of life insurance business is that there is large block of existing portfolio prodiving stable income in addition to new business which is to add on to the growth. Lower new business during MCO mainly due to face to face restriction imposed by Bank Negara. Agents will catch up their new business as this is their bread and butter.
From Allianz annual report, Allianz signed on as preferred partner for Pos Malaysia since Q4 2020. General insurance industry would know that Pos Malaysia is one of the major business sources for many general insurers given its large network of branches nationwide.
When the hospital business is getting lesser during pandemic and people avoid visiting hospitals / avoid seeking medical treatment during COVID-19 pandemic, ....on the other hand, it means lesser medical claims against the insurance companies, especially life insurance companies.
During pandemic, the positive effect on life insurance companies is lower medical claims. Generally, medical portfolio is the largest portfolio of most life insurance companies and usually claim ratio is also very high due to expensive medical + inflation.
Lower claims against insurance companies will give substantial savings and profits to insurance companies.
Allianz General will see better profit from its motor business (lower motor claims due to reduced traffics on the road) and Allianz Life will see better profit from its medical business (lower medical claims).
Do you wonder why the insurance companies do not really suffer substantial medical claims despite pandemic?
It is because if the policyholder is a confirmed COVID-19 case, he/she needs to admit to the designated government hospital instead of private hospital, and essentially the costs are borne by the government hospitals.
Cost to insurance companies is just RM50 or RM100 per day for hospitalised to government hospital.
Secondly, the number of cases in Malaysia is not that high and under control I would say.
PE is not 4.61 times as shown. You need to apply diluted EPS by assuming all ICPS are converted to ordinary shares. The trailing-twelve-month PE is about 9 times.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
RedEagle
3,194 posts
Posted by RedEagle > 2020-05-06 18:44 | Report Abuse
The Board of Directors of MBSB has recommended a Single-Tier Final Dividend of 3.0 sen net per Ordinary Share for the financial year ended 31 December 2019 ("Proposed Dividend").
Based on the total number of ordinary shares issued of 6,713,401,615 as at 31 December 2019, the Proposed Dividend payable would be approximately RM201.4 million.
The Board of Directors has determined that the option to reinvest via the Dividend Reinvestment Plan ("DRP") shall apply to the entire portion of the Proposed Dividend. The approval for the Proposed Dividend will be sought at the coming Annual General Meeting.
Under DRP, shareholders will have the following options in respect of the electable portion:-
(a) elect to exercise the option and thereby reinvest the entire electable portion (or a part thereof) at the issue price of the new MBSB shares ("DRP Price") and to receive cash for the remaining portion of the dividend (in the event that only part of the electable portion is reinvested); or
(b) elect not to exercise the option to reinvest and thereby receive their entire dividend entitlement wholly in cash.
There will be no brokerage fees and other related transaction costs payable by shareholders on the new MBSB shares allotted pursuant to the DRP.
The Books Closure date in respect of the Proposed Dividend will be announced after the Annual General Meeting.
This announcement is dated 6 May 2020.